Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels

Frontiers in Endocrinology

Volumn 2, Issue NOV, 2011, Pages

  Albu, Roxana I ^a,b   Constantinescu, Stefan N ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

Cell surface traffic; Cytokine receptor; Endoglycosidase H; ER maturation; Jak2; N glycosylation; Signal transduction; Thrombopoietin

Indexed keywords

EID: 84874361202     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00071     Document Type: Article

References (45)

1. Ballmaier, M., Germeshausen, M., Schulze, H., Cherkaoui, K., Lang, S., Gaudig, A., Krukemeier, S., Eilers, M., Strauss, G., and Welte, K. (2001). c-mpl Mutations are the cause of congenital amegakaryocytic throm-bocytopenia. Blood 97, 139-146.
2. Bazan,J. F. (1990). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U.S.A. 87, 6934-6938.
3. Bolander, F. F. Jr. (1999). Regulation of prolactin receptor glycosylation and its role in receptor location. Mol. Cell. Endocrinol. 149, 85-92.
4. Buteau, H., Pezet, A., Ferrag, F., Perrot-Applanat, M., Kelly, P. A., and Edery, M. (1998). N-glycosylation of the prolactin receptor is not required for activation of gene transcrip-tion but is crucial for its cell sur-face targeting. Mol. Endocrinol. 12, 544-555.
5. Dalal, I., Arpaia, E., Dadi, H., Kulka-rni, S., Squire, J., and Roifman, C. M. (1998). Cloning and character-ization of the human homolog of mouse Jak2. Blood 91, 844-851.
6. Deane, C. M., Kroemer, R. T., and Richards, W. G. (1997). A structural model of the human thrombopoi-etin receptor complex. J. Mol. Graph. Model. 15, 170-178, 185-178.
7. Ding, D. X., Vera, J. C., Heaney, M. L., and Golde, D. W. (1995). N-glycosylation of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit is essential for ligand bind-ing and signal transduction. J. Biol. Chem. 270, 24580-24584.
8. Drachman, J. G., Griffin, J. D., and Kaushansky, K. (1995). The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J. Biol. Chem. 270, 4979-4982.
9. Drachman, J. G., and Kaushansky, K. (1995). Structure and function of the cytokine receptor superfamily. Curr. Opin. Hematol. 2, 22-28.
10. Drachman, J. G., Millett, K. M., and Kaushansky, K. (1999). Throm-bopoietin signal transduction requires functional JAK2, not TYK2. J. Biol. Chem. 274, 13480-13484.
11. Dumoutier, L., Van Roost, E., Colau, D., and Renauld, J. C. (2000). Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 97, 10144-10149.
12. El-Harith El, H. A., Roesl, C., Ball-maier, M., Germeshausen, M., Frye-Boukhriss, H., Von Neuhoff, N., Becker, C., Nurnberg, G., Nurn-berg, P., Ahmed, M. A., Hubener, J., Schmidtke, J., Welte, K., and Stuhrmann, M. (2009). Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene. Br. J. Haematol. 144, 185-194.
13. Ezumi, Y., Takayama, H., and Okuma, M. (1995). Thrombopoietin, c-Mpl ligand, induces tyrosine phosphory-lation of Tyk2,JAK2,and STAT3,and enhances agonists-induced aggrega-tion in platelets in vitro. FEBS Lett. 374, 48-52.
14. Feese, M. D., Tamada, T., Kato, Y., Maeda, Y., Hirose, M., Matsukura, Y., Shigematsu, H., Muto, T., Mat-sumoto, A., Watarai, H., Ogami, K., Tahara, T., Kato, T., Miyazaki, H., and Kuroki, R. (2004). Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc. Natl. Acad. Sci. U.S.A. 101, 1816-1821.
15. Fox, N. E., Chen, R., Hitchcock, I., Keates-Baleeiro, J., Frangoul, H., and Geddis, A. E. (2009). Com-pound heterozygous c-Mpl muta-tions in a child with congen-ital amegakaryocytic thrombocy-topenia: functional characterization and a review of the literature. Exp. Hematol. 37, 495-503.
16. Gerland, K., Bataille-Simoneau, N., Basle, M., Fourcin, M., Gascan, H., and Mercier, L. (2000). Acti-vation of the Jak/Stat signal trans-duction pathway in GH-treated rat osteoblast-like cells in culture. Mol. Cell. Endocrinol. 168, 1-9.
17. Germeshausen, M., Ballmaier, M., and Welte, K. (2006). MPL muta-tions in 23 patients suffering from congenital amegakaryocytic throm-bocytopenia: the type of mutation predicts the course of the disease. Hum. Mutat. 27, 296.
18. Huang, L. J., Constantinescu, S. N., and Lodish, H. F. (2001). The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of ery-thropoietin receptor. Mol. Cell 8, 1327-1338.
19. Kamikubo, Y., Dellas, C., Loskutoff, D. J., Quigley, J. P., and Ruggeri, Z. M. (2008). Contribution of lep-tin receptor N-linked glycans to leptin binding. Biochem. J. 410, 595-604.
20. Kaushansky, K., Lok, S., Holly, R. D., Broudy, V. C., Lin, N., Bailey, M. C., Forstrom, J. W., Buddle, M. M., Oort, P. J., Hagen, F. S., Roth, G. J., Papayannopoulou, T., and Fos-ter, D. C. (1994). Promotion of megakaryocyte progenitor expan-sion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369, 568-571.
21. Lannutti, B. J., Epp, A., Roy, J., Chen, J., and Josephson, N. C. (2009). Incom-plete restoration of Mpl expres-sion in the mpl-/-mouse pro-duces partial correction of the stem cell-repopulating defect and para-doxical thrombocytosis. Blood 113, 1778-1785.
22. Liu, X., Constantinescu, S. N., Sun, Y., Bogan, J. S., Hirsch, D., Weinberg, R. A., and Lodish, H. F. (2000). Gen-eration of mammalian cells stably expressing multiple genes at prede-termined levels. Anal. Biochem. 280, 20-28.
23. Miyakawa, Y., Oda, A., Druker, B. J., Kato, T., Miyazaki, H., Handa, M., and Ikeda, Y. (1995). Recombinant thrombopoietin induces rapid pro-tein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 86, 23-27.
24. Miyakawa, Y., Oda, A., Druker, B. J., Miyazaki,H.,Handa,M.,Ohashi,H., and Ikeda, Y. (1996). Thrombopoi-etin induces tyrosine phosphoryla-tion of Stat3 and Stat5 in human blood platelets. Blood 87, 439-446.
25. Moliterno, A. R., Hankins, W. D., and Spivak,J. L. (1998). Impaired expres-sion of the thrombopoietin receptor by platelets from patients with poly-cythemia vera. N.Engl.J.Med.338, 572-580.
26. Moliterno, A. R., and Spivak, J. L. (1999). Posttranslational process-ing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 94, 2555-2561.
27. Moliterno, A. R., Williams, D. M., Gutierrez-Alamillo, L. I., Salvatori, R., Ingersoll, R. G., and Spivak, J. L. (2004). Mpl Baltimore: a thrombopoietin receptor polymor-phism associated with thrombocyto-sis. Proc. Natl. Acad. Sci. U.S.A. 101, 11444-11447.
28. Murphy, J. M., Soboleva, T. A., Mirza, S., Ford, S. C., Olsen, J. E., Chen, J., and Young, I. G. (2008). Clarifica-tion of the role of N-glycans on the common beta-subunit of the human IL-3, IL-5 and GM-CSF receptors and the murine IL-3 beta-receptor in ligand-binding and receptor acti-vation. Cytokine 42, 234-242.
29. Niu, L., Heaney, M. L., Vera, J. C., and Golde, D. W. (2000). High-affinity binding to the GM-CSF receptor requires intact N-glycosylation sites in the extracellular domain of the beta subunit. Blood 95, 3357-3362.
30. Onishi, M., Mui, A. L., Morikawa, Y., Cho, L., Kinoshita, S., Nolan, G. P., Gorman, D. M., Miyajima, A., and Kitamura, T. (1996). Identifica-tion of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood 88, 1399-1406.
31. Palacios, R., and Steinmetz, M. (1985). Il-3-dependent mouse clones that express B-220 surface antigen, con-tain Ig genes in germ-line configu-ration, and generate B lymphocytes in vivo. Cell 41, 727-734.
32. Pear,W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
33. Pellegrini, S., John, J., Shearer, M., Kerr, I. M., and Stark, G. R. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
34. Royer, Y., Staerk, J., Costuleanu, M., Courtoy, P. J., and Constantinescu, S. N. (2005). Janus kinases affect thrombopoietin receptor cell sur-face localization and stability. J. Biol. Chem. 280, 27251-27261.
35. Sabath, D. F., Kaushansky, K., and Broudy, V. C. (1999). Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in con-stitutive cell growth and loss of thrombopoietin binding. Blood 94, 365-367.
36. Seubert, N., Royer, Y., Staerk, J., Kubatzky, K. F., Moucadel, V., Krishnakumar, S., Smith, S. O., and Constantinescu, S. N. (2003). Active and inactive orientations of the transmembrane and cytoso-lic domains of the erythropoi-etin receptor dimer. Mol. Cell 12, 1239-1250.
37. Skoda, R. C., Seldin, D. C., Chiang, M. K., Peichel, C. L., Vogt, T. F., and Leder, P. (1993). Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 12, 2645-2653.
38. Solar, G. P., Kerr, W. G., Zeigler, F. C., Hess, D., Donahue, C., De Sauvage, F. J., and Eaton, D. L. (1998). Role of c-mpl in early hematopoiesis. Blood 92, 4-10.
39. Teofili, L., and Larocca, L. M. (2011). Advances in understanding the pathogenesis of familial thrombo-cythaemia. Br. J. Haematol. 152, 701-712.
40. Tiedt, R., Coers, J., Ziegler, S., Wiest-ner, A., Hao-Shen, H., Bornmann, C., Schenkel, J., Karakhanova, S., De Sauvage, F. J., Jackson, C. W., and Skoda, R. C. (2009). Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differen-tiated megakaryocytes. Blood 113, 1768-1777.
41. Tijssen, M. R., Di Summa, F., Van Den Oudenrijn, S., Zwaginga, J. J., Van Der Schoot, C. E., Voermans, C., and De Haas, M. (2008). Func-tional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congen-ital amegakaryocytic thrombocy-topenia. Br. J. Haematol. 141, 808-813.
42. Vigon, I., Florindo, C., Fichelson, S., Guenet, J. L., Mattei, M. G., Souyri, M., Cosman, D., and Gisselbrecht, S. (1993). Charac-terization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromo-somal location and evidence for a function in cell growth. Oncogene 8, 2607-2615.
43. Vigon, I., Mornon, J. P., Cocault, L., Mitjavila, M. T., Tambourin, P., Gis-selbrecht, S., and Souyri, M. (1992). Molecular cloning and characteriza-tion of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfam-ily. Proc. Natl. Acad. Sci. U.S.A. 89, 5640-5644.
44. Waetzig, G. H., Chalaris, A., Rosen-stiel, P., Suthaus, J., Holland, C., Karl, N., Valles Uriarte, L., Till, A., Scheller, J., Grotzinger, J., Schreiber, S., Rose-John, S., and Seegert, D. (2010). N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer gly-coprotein 130. J. Biol. Chem. 285, 1781-1789.
45. Yoshimura, A., Zimmers, T., Neumann, D., Longmore, G., Yoshimura, Y., and Lodish, H. F. (1992). Muta-tions in the Trp-Ser-X-Trp-Ser motif of the erythropoietin recep-tor abolish processing, ligand binding, and activation of the receptor. J. Biol. Chem. 267, 11619-11625.